Sunny Tan
President
biotechnology
Invitrocue
Australia
Biography
Sunny Tan is Senior Vice President - Scientific Affairs and Corporate Development of the Company. Tan will commence immediately as Senior VP, Scientific Affairs and Corporate Development, leading the company’s engagement with scientific and commercial partners. Dr Tan is a well-regarded life sciences and health innovation professional, with broad experience commercialising new technologies to effect better healthcare. Dr Tan’s experience includes the commercialisation of biomedical technologies as Vice President of Exploit Technologies, the commercialisation company for Singapore’s Agency for Science, Technology and Research (A*STAR), and investment into early stage biomedical companies at Singapore government investment holding company Temasek Holdings. Dr Tan holds a PhD in Biochemistry and Molecular Biology (Australian National University), and a BSc in Biotechnology with First Class Honours (University of New South Wales). Serving as Scientific Adviser to InvitroCue since 2016.
Research Interest
biotechnology biomedical technologies
